Back to search
Impaired Attention
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Impaired Attention trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Impaired Attention trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This trial aims to evaluate the feasibility, safety, and acceptability of a virtual reality (VR)-based cognitive stimulation game to reduce postoperative deliri…
A large series of recent studies have documented the frequency of the slowing of the action in brain diseases, especially vascular and neurodegenerative disease…
Rationale: Patients with acquired brain injury (ABI) may suffer from persistent cognitive deficits and/or subjective cognitive complaints, especially in the dom…
The purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day…
The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12…
The main objective is to compare changes in information processing speed after 30 days of intervention in participants with a dysexecutive mild cognitive impair…
Cognitive reserve refers to the brain's ability to maintain cognitive performance despite age-related changes or neuropathology. Enhancing cognitive reserve is…
A recently completed study suggested that processing speed and attention (PS/A) oriented cognitive training (VSOP) produced robust effect on PS/A and working me…